mbiomics GmbH
PrivateLast Round
Series A
Apr 28, 2026
Total Funding Raised
$70.2M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
mbiomics GmbH operates in Healthcare & Life Sciences and is based in Munich. Its latest recorded funding round was a Series A round in April 2026.
mbiomics GmbH is a biotechnology company that develops live bacterial therapeutics and microbiome-based diagnostic platforms for severe and chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
mbiomics GmbH Comparables
Compare mbiomics GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Microbiotica | 86% | |
| Kanvas Biosciences | 82% | |
| Enterome | 79% |
For institutional investors. Book with your work email.
mbiomics GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 28, 2026 | ||||
| Series A | Mar 23, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
mbiomics GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MIG Capital | Series A |
| Bayern Kapital | Series A |
| High-Tech Gründerfonds | Series A |
| MIG Fonds | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
$35M round led by Bayern Kapital and MIG Fonds.
- Apr 29, 2026
Lead candidate MBX-116 preparing for clinical evaluation for advanced melanoma.
For institutional investors. Book with your work email.
mbiomics GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about mbiomics GmbH's valuation, stock price, and market status.
Is mbiomics GmbH a public or private company?
mbiomics GmbH is a private company.
What is the current stock price of mbiomics GmbH?
mbiomics GmbH is a private company, so its shares have no public market price. Caplight tracks mbiomics GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is mbiomics GmbH worth (valuation)?
Valuation information for mbiomics GmbH is not publicly available.
Can I buy mbiomics GmbH stock?
mbiomics GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was mbiomics GmbH's last funding round?
mbiomics GmbH's most recent funding round was Series A on April 28, 2026.
Who are the main investors in mbiomics GmbH?
Key investors in mbiomics GmbH include MIG Capital, Bayern Kapital, MIG Fonds.
Will mbiomics GmbH IPO soon?
No public IPO plans have been announced for mbiomics GmbH.
How can I track mbiomics GmbH secondary market activity?
Caplight tracks bids, offers, and trades in mbiomics GmbH's shares on secondary markets.